Lisanti Capital Growth LLC bought a new position in shares of Astronics Corporation (NASDAQ:ATRO – Free Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm bought 18,270 shares of the aerospace company’s stock, valued at approximately $991,000. Lisanti Capital Growth LLC owned approximately 0.05% of Astronics as of its most recent SEC filing.
Several other hedge funds have also recently modified their holdings of the company. Vanguard Group Inc. lifted its position in shares of Astronics by 2.0% during the 4th quarter. Vanguard Group Inc. now owns 1,975,693 shares of the aerospace company’s stock worth $107,162,000 after buying an additional 39,527 shares in the last quarter. Capital International Investors bought a new position in shares of Astronics during the 3rd quarter worth approximately $64,173,000. Luxor Capital Group LP bought a new position in shares of Astronics during the 3rd quarter worth approximately $52,698,000. Millennium Management LLC lifted its position in shares of Astronics by 80.1% during the 1st quarter. Millennium Management LLC now owns 746,956 shares of the aerospace company’s stock worth $18,054,000 after buying an additional 332,133 shares in the last quarter. Finally, Private Capital Management LLC lifted its position in shares of Astronics by 39.4% during the 3rd quarter. Private Capital Management LLC now owns 561,257 shares of the aerospace company’s stock worth $25,599,000 after buying an additional 158,714 shares in the last quarter. Institutional investors own 56.68% of the company’s stock.
Astronics Price Performance
Astronics stock opened at $80.86 on Friday. Astronics Corporation has a 12 month low of $27.27 and a 12 month high of $86.27. The company has a current ratio of 2.97, a quick ratio of 1.63 and a debt-to-equity ratio of 2.07. The business’s 50 day simple moving average is $72.93 and its 200 day simple moving average is $66.86. The company has a market cap of $2.90 billion, a price-to-earnings ratio of 68.53 and a beta of 1.10.
Analyst Upgrades and Downgrades
Several equities analysts have commented on ATRO shares. Wall Street Zen raised shares of Astronics from a “buy” rating to a “strong-buy” rating in a research report on Saturday, February 28th. Zacks Research cut shares of Astronics from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, May 13th. Truist Financial upgraded Astronics to a “strong-buy” rating in a research note on Monday, May 4th. Finally, Weiss Ratings reiterated a “sell (d-)” rating on shares of Astronics in a research note on Monday, April 20th. Two investment analysts have rated the stock with a Strong Buy rating, two have given a Buy rating, one has issued a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $77.33.
Check Out Our Latest Stock Report on Astronics
Astronics Company Profile
Astronics Corporation (NASDAQ: ATRO) is a global leader in the design and manufacture of advanced technologies primarily for the aerospace, defense and semiconductor industries. Headquartered in East Aurora, New York, the company was founded in 1968 and has grown through a combination of internal development and strategic acquisitions. Astronics operates multiple business units focused on power conversion, distribution and control; cabin electronics and connectivity; aircraft lighting and safety solutions; and automated test systems.
The company’s aerospace products include onboard power generation and management systems, in-flight entertainment and connectivity hardware, LED and fluorescent lighting for aircraft cabins and cockpits, and safety equipment such as escape slide power units.
Read More
- Five stocks we like better than Astronics
- Workday Validates AI Flywheel: Stock Price Recovery Begins
- HubSpot at 2019 Levels Is an Opportunity—Not a Warning
- Was Decker’s Double Beat a Bullish Signal—Or Mere HOKA’s-Pocus?
- Kiniksa Pharmaceuticals Still Has Room to Run After 100% Rally
Receive News & Ratings for Astronics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astronics and related companies with MarketBeat.com's FREE daily email newsletter.
